Skip to main content

Table 2 Hospital-acquired respiratory viral infections (HARVI) in patients at risk

From: Droplet precautions on-site (DroPS) during the influenza season 2018/2019: a possible alternative to single room isolation for respiratory viral infections

Outcome, no (%)

DroPS wards

(n = 741)

Regular wards

(n = 293)

Risk difference in % (95% CI)

P value

Primary outcome

Influenza/RSV positive, no. (%)

2 (0.3)

2 (0.7)

−0.4 (− 1.6 to 0.8)

0.684

Secondary outcomes

Any respiratory virus positive, no. (%)

5 (0.7)

2 (0.7)

0.0 (− 1.1 to 1.1)

0.9

Clinical diagnosis, no. (%)

17 (2.3)

2 (0.7)

1.6 (− 0.05 to 3.2)

0.138

Influenza/RSV positive – or no Influenza/RSV test performed, no. (%)

4 (0.5)

2 (0.7)

−0.2 (− 1.3 to 1.1)

0.9

Any respiratory virus positive – or no complete viral panel test performed, no. (%)

9 (1.2)

2 (0.7)

0.5 (− 0.9 to 2.0)

0.678

  1. No. = number; (%) = percent; RSV = respiratory syncytial virus; DroPS (droplet precautions on-site); regular wards: pathogen-based single room strategy. Positive risk difference indicates regular is better than DroPS